| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.795 | 0.004 | 0.795 | Vasodilator, peripheral | 0.653 0.01 DBMET01914 0.67 0.009 DBMET01915 0.646 0.011 DBMET01916 0.375 0.064 DBMET01918 0.452 0.04 DBMET01917 0.263 0.118 DBMET01919 | ||
| 0.738 | 0.003 | 0.738 | Anesthetic local | 0.512 0.004 DBMET01914 0.579 0.004 DBMET01915 0.196 0.033 DBMET01916 0.272 0.016 DBMET01918 0.115 0.071 DBMET01917 0.226 0.025 DBMET01919 | ||
| 0.665 | 0.008 | 0.727 | Spasmolytic | 0.67 0.008 DBMET01914 0.616 0.011 DBMET01915 0.727 0.005 DBMET01916 0.628 0.01 DBMET01918 0.622 0.011 DBMET01917 0.556 0.017 DBMET01919 | DBMET01916 | |
| 0.653 | 0.012 | 0.675 | Cholesterol antagonist | 0.636 0.014 DBMET01914 0.652 0.012 DBMET01915 0.675 0.01 DBMET01916 0.632 0.015 DBMET01918 0.672 0.01 DBMET01917 0.646 0.013 DBMET01919 | DBMET01916 | |
| 0.607 | 0.004 | 0.657 | Anesthetic general | 0.586 0.005 DBMET01914 0.498 0.008 DBMET01915 0.657 0.004 DBMET01916 0.261 0.045 DBMET01918 0.543 0.005 DBMET01917 0.161 0.103 DBMET01919 | DBMET01916 | |
| 0.589 | 0.008 | 0.589 | Vasodilator, coronary | 0.499 0.016 DBMET01914 0.467 0.02 DBMET01915 0.52 0.013 DBMET01916 0.369 0.047 DBMET01918 0.497 0.016 DBMET01917 0.337 0.062 DBMET01919 | ||
| 0.584 | 0.038 | 0.699 | Caspase 9 stimulant | 0.422 0.098 DBMET01914 0.364 0.134 DBMET01915 0.699 0.024 DBMET01916 0.477 0.069 DBMET01917 | DBMET01916 | |
| 0.481 | 0.014 | 0.481 | Hypolipemic | 0.43 0.02 DBMET01914 0.412 0.023 DBMET01915 0.457 0.017 DBMET01916 0.338 0.039 DBMET01918 0.4 0.025 DBMET01917 0.299 0.049 DBMET01919 | ||
| 0.497 | 0.03 | 0.497 | Histamine release inhibitor | 0.472 0.04 DBMET01914 0.359 0.096 DBMET01915 0.288 0.13 DBMET01916 0.469 0.041 DBMET01918 0.35 0.1 DBMET01919 | ||
| 0.521 | 0.068 | 0.677 | Apoptosis agonist | 0.486 0.079 DBMET01914 0.457 0.088 DBMET01915 0.677 0.035 DBMET01916 0.673 0.035 DBMET01917 0.237 0.229 DBMET01919 | DBMET01916 | |
| 0.477 | 0.037 | 0.477 | Thyroid hormone antagonist | 0.409 0.053 DBMET01914 0.408 0.053 DBMET01915 | ||
| 0.471 | 0.037 | 0.653 | Aldehyde oxidase inhibitor | 0.653 0.013 DBMET01914 0.296 0.067 DBMET01915 0.191 0.109 DBMET01918 | DBMET01914 | |
| 0.435 | 0.018 | 0.435 | Vasodilator | 0.377 0.027 DBMET01914 0.34 0.036 DBMET01915 0.326 0.04 DBMET01916 0.256 0.066 DBMET01918 0.302 0.047 DBMET01917 0.236 0.078 DBMET01919 | ||
| 0.456 | 0.052 | 0.664 | Transcription factor NF kappa B inhibitor | 0.38 0.068 DBMET01914 0.463 0.05 DBMET01915 0.58 0.034 DBMET01916 0.212 0.157 DBMET01918 0.664 0.025 DBMET01917 0.244 0.132 DBMET01919 | DBMET01917 | |
| 0.403 | 0.008 | 0.403 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.302 0.023 DBMET01914 0.266 0.036 DBMET01915 0.2 0.072 DBMET01916 | ||
| 0.437 | 0.044 | 0.437 | Thyroid hormone beta antagonist | 0.37 0.062 DBMET01914 0.363 0.064 DBMET01915 | ||
| 0.384 | 0.018 | 0.384 | P-glycoprotein inhibitor | 0.195 0.068 DBMET01914 0.199 0.064 DBMET01915 0.181 0.079 DBMET01916 0.155 0.11 DBMET01917 | ||
| 0.353 | 0.001 | 0.353 | Estrogen-related receptor beta agonist | 0.295 0.001 DBMET01914 0.176 0.003 DBMET01915 0.15 0.004 DBMET01916 0.153 0.004 DBMET01918 0.094 0.032 DBMET01917 0.106 0.019 DBMET01919 | ||
| 0.377 | 0.026 | 0.377 | Psychostimulant | 0.217 0.071 DBMET01914 0.268 0.052 DBMET01915 0.152 0.115 DBMET01916 | ||
| 0.372 | 0.027 | 0.403 | Sodium/bile acid cotransporter inhibitor | 0.365 0.031 DBMET01914 0.403 0.016 DBMET01915 0.32 0.062 DBMET01916 0.351 0.039 DBMET01918 0.326 0.057 DBMET01917 0.369 0.029 DBMET01919 | DBMET01915 | |
| 0.405 | 0.061 | 0.528 | Immunosuppressant | 0.337 0.094 DBMET01914 0.292 0.12 DBMET01915 0.528 0.026 DBMET01916 0.233 0.163 DBMET01918 0.508 0.031 DBMET01917 0.212 0.185 DBMET01919 | DBMET01916 | |
| 0.369 | 0.038 | 0.436 | Calcium channel activator | 0.303 0.089 DBMET01914 0.436 0.014 DBMET01915 0.239 0.16 DBMET01918 0.212 0.196 DBMET01917 0.334 0.062 DBMET01919 | DBMET01915 | |
| 0.322 | 0.004 | 0.322 | Calcium antagonist | 0.244 0.009 DBMET01914 0.116 0.037 DBMET01915 0.129 0.03 DBMET01918 | ||
| 0.433 | 0.119 | 0.748 | Antiinflammatory | 0.314 0.202 DBMET01914 0.324 0.194 DBMET01915 0.736 0.024 DBMET01916 0.748 0.023 DBMET01917 | DBMET01917 | |
| 0.316 | 0.004 | 0.316 | TRPA1 agonist | 0.176 0.017 DBMET01914 0.285 0.005 DBMET01915 0.146 0.034 DBMET01916 0.188 0.013 DBMET01918 0.123 0.055 DBMET01917 0.194 0.012 DBMET01919 | ||
| 0.308 | 0.004 | 0.371 | Vanilloid agonist | 0.253 0.005 DBMET01914 0.371 0.004 DBMET01915 0.172 0.009 DBMET01916 0.206 0.006 DBMET01918 0.19 0.007 DBMET01917 0.255 0.005 DBMET01919 | DBMET01915 | |
| 0.363 | 0.06 | 0.599 | Antithrombotic | 0.293 0.092 DBMET01914 0.224 0.15 DBMET01915 0.599 0.016 DBMET01916 0.326 0.074 DBMET01918 0.568 0.02 DBMET01917 0.306 0.084 DBMET01919 | DBMET01916 | |
| 0.343 | 0.041 | 0.376 | Cardiotonic | 0.33 0.045 DBMET01914 0.275 0.067 DBMET01915 0.376 0.033 DBMET01916 0.177 0.143 DBMET01918 0.229 0.097 DBMET01917 | DBMET01916 | |
| 0.355 | 0.054 | 0.408 | Apoptosis antagonist | 0.325 0.069 DBMET01914 0.315 0.075 DBMET01915 0.408 0.036 DBMET01916 0.389 0.042 DBMET01917 | DBMET01916 | |
| 0.343 | 0.043 | 0.514 | DNA damaging | 0.304 0.055 DBMET01914 0.272 0.069 DBMET01915 0.514 0.013 DBMET01916 0.166 0.15 DBMET01918 0.507 0.013 DBMET01917 0.163 0.154 DBMET01919 | DBMET01916 | |
| 0.298 | 0.019 | 0.318 | Neurotrophic factor enhancer | 0.279 0.025 DBMET01914 0.318 0.014 DBMET01915 0.299 0.018 DBMET01916 0.299 0.018 DBMET01917 | DBMET01915 | |
| 0.299 | 0.021 | 0.299 | Lipocortins synthesis antagonist | 0.236 0.038 DBMET01914 0.149 0.107 DBMET01915 0.187 0.066 DBMET01916 0.17 0.08 DBMET01918 | ||
| 0.286 | 0.017 | 0.39 | Nav1.2 sodium channel blocker | 0.372 0.008 DBMET01914 0.321 0.013 DBMET01915 0.153 0.055 DBMET01916 0.39 0.007 DBMET01918 0.341 0.011 DBMET01919 | DBMET01918 | |
| 0.296 | 0.029 | 0.296 | Non-steroidal antiinflammatory agent | 0.202 0.07 DBMET01915 0.253 0.041 DBMET01916 0.19 0.079 DBMET01917 | ||
| 0.28 | 0.022 | 0.342 | Lipid peroxidase inhibitor | 0.315 0.017 DBMET01914 0.23 0.031 DBMET01915 0.342 0.014 DBMET01916 0.208 0.039 DBMET01918 0.336 0.014 DBMET01917 0.165 0.058 DBMET01919 | DBMET01916 | |
| 0.272 | 0.014 | 0.373 | Alkylator | 0.257 0.016 DBMET01914 0.204 0.025 DBMET01915 0.359 0.009 DBMET01916 0.222 0.021 DBMET01918 0.373 0.009 DBMET01917 0.218 0.022 DBMET01919 | DBMET01917 | |
| 0.303 | 0.047 | 0.303 | Interleukin agonist | 0.251 0.078 DBMET01915 0.267 0.067 DBMET01916 0.251 0.078 DBMET01917 | ||
| 0.261 | 0.011 | 0.318 | ATPase inhibitor | 0.263 0.011 DBMET01914 0.276 0.009 DBMET01915 0.318 0.005 DBMET01916 0.274 0.009 DBMET01917 | DBMET01916 | |
| 0.304 | 0.06 | 0.585 | Antioxidant | 0.356 0.045 DBMET01914 0.332 0.051 DBMET01915 0.585 0.012 DBMET01916 0.305 0.06 DBMET01918 0.582 0.013 DBMET01917 0.287 0.067 DBMET01919 | DBMET01916 | |
| 0.253 | 0.02 | 0.356 | Heat shock protein 90 antagonist | 0.356 0.005 DBMET01914 0.316 0.008 DBMET01915 0.307 0.009 DBMET01916 0.285 0.012 DBMET01917 | DBMET01914 | |
| 0.237 | 0.006 | 0.443 | Vanilloid 1 agonist | 0.223 0.008 DBMET01914 0.443 0.003 DBMET01915 0.228 0.007 DBMET01916 0.191 0.014 DBMET01918 0.312 0.004 DBMET01917 0.27 0.005 DBMET01919 | DBMET01915 | |
| 0.248 | 0.018 | 0.248 | Cholesterol synthesis inhibitor | 0.18 0.032 DBMET01914 0.124 0.061 DBMET01915 0.115 0.069 DBMET01916 0.214 0.024 DBMET01918 0.109 0.076 DBMET01919 | ||
| 0.246 | 0.018 | 0.259 | 5 Hydroxytryptamine 3E antagonist | 0.259 0.013 DBMET01914 0.255 0.014 DBMET01915 0.223 0.033 DBMET01918 0.225 0.031 DBMET01919 | DBMET01914 | |
| 0.276 | 0.052 | 0.276 | Gastrin inhibitor | 0.25 0.079 DBMET01915 0.186 0.169 DBMET01919 | ||
| 0.228 | 0.005 | 0.228 | Prolactin inhibitor | 0.162 0.018 DBMET01914 0.142 0.026 DBMET01915 | ||
| 0.233 | 0.011 | 0.254 | Cyclooxygenase 3 inhibitor | 0.132 0.064 DBMET01914 0.151 0.047 DBMET01915 0.254 0.008 DBMET01916 0.214 0.014 DBMET01917 | DBMET01916 | |
| 0.34 | 0.125 | 0.34 | 5 Hydroxytryptamine release inhibitor | |||
| 0.21 | 0.004 | 0.219 | Purinergic P2X2 antagonist | 0.212 0.004 DBMET01914 0.219 0.004 DBMET01915 0.206 0.004 DBMET01916 0.207 0.004 DBMET01918 0.148 0.012 DBMET01917 0.198 0.005 DBMET01919 | DBMET01915 | |
| 0.263 | 0.058 | 0.263 | Cyclic AMP phosphodiesterase inhibitor | 0.234 0.072 DBMET01914 0.199 0.094 DBMET01916 | ||
| 0.27 | 0.065 | 0.473 | Hypoglycemic | 0.237 0.085 DBMET01914 0.241 0.082 DBMET01915 0.473 0.018 DBMET01916 0.456 0.02 DBMET01917 | DBMET01916 | |
| 0.213 | 0.01 | 0.213 | Gastric antisecretory | 0.18 0.016 DBMET01914 0.198 0.013 DBMET01915 0.208 0.011 DBMET01918 0.208 0.011 DBMET01919 | ||
| 0.22 | 0.017 | 0.22 | Arachidonic acid antagonist | 0.199 0.034 DBMET01914 0.162 0.074 DBMET01915 0.146 0.093 DBMET01916 0.165 0.071 DBMET01918 | ||
| 0.24 | 0.041 | 0.24 | Insulin sensitizer | 0.206 0.067 DBMET01914 0.237 0.042 DBMET01915 0.186 0.088 DBMET01916 0.144 0.141 DBMET01917 0.154 0.128 DBMET01919 | ||
| 0.278 | 0.083 | 0.325 | Lipoxygenase inhibitor | 0.325 0.059 DBMET01914 0.314 0.065 DBMET01915 | DBMET01914 | |
| 0.226 | 0.033 | 0.384 | Protein kinase stimulant | 0.162 0.061 DBMET01914 0.217 0.036 DBMET01915 0.349 0.012 DBMET01916 0.384 0.009 DBMET01917 | DBMET01917 | |
| 0.217 | 0.024 | 0.217 | Calcium channel blocker | 0.138 0.07 DBMET01914 | ||
| 0.225 | 0.033 | 0.36 | Melanin inhibitor | 0.198 0.041 DBMET01914 0.243 0.03 DBMET01915 0.36 0.015 DBMET01916 0.273 0.025 DBMET01917 | DBMET01916 | |
| 0.23 | 0.049 | 0.235 | Nitric-oxide synthase stimulant | 0.172 0.149 DBMET01914 0.216 0.065 DBMET01915 0.232 0.046 DBMET01916 0.235 0.044 DBMET01917 | DBMET01917 | |
| 0.202 | 0.021 | 0.235 | Farnesoid X receptor antagonist | 0.183 0.028 DBMET01914 0.235 0.014 DBMET01915 0.149 0.053 DBMET01916 0.133 0.078 DBMET01918 0.129 0.083 DBMET01919 | DBMET01915 | |
| 0.323 | 0.143 | 0.691 | Cyclophilin D inhibitor | 0.276 0.185 DBMET01914 0.362 0.114 DBMET01915 0.691 0.015 DBMET01916 0.67 0.017 DBMET01917 0.235 0.23 DBMET01919 | DBMET01916 | |
| 0.204 | 0.029 | 0.226 | Toll-Like receptor antagonist | 0.226 0.022 DBMET01914 0.189 0.035 DBMET01915 0.114 0.095 DBMET01916 0.13 0.072 DBMET01917 | DBMET01914 | |
| 0.245 | 0.07 | 0.483 | Free radical scavenger | 0.297 0.053 DBMET01914 0.272 0.06 DBMET01915 0.462 0.02 DBMET01916 0.15 0.145 DBMET01918 0.483 0.018 DBMET01917 | DBMET01917 | |
| 0.196 | 0.023 | 0.196 | Antibacterial (Helicobacter pylori) | 0.155 0.042 DBMET01914 0.159 0.039 DBMET01915 0.142 0.054 DBMET01916 0.132 0.065 DBMET01918 0.127 0.071 DBMET01917 0.134 0.062 DBMET01919 | ||
| 0.256 | 0.092 | 0.256 | Ca(v)3.3 blocker | 0.217 0.158 DBMET01914 0.218 0.155 DBMET01915 | ||
| 0.257 | 0.093 | 0.45 | Immunostimulant | 0.208 0.115 DBMET01914 0.225 0.107 DBMET01915 0.45 0.037 DBMET01916 0.237 0.102 DBMET01918 0.383 0.055 DBMET01917 0.206 0.117 DBMET01919 | DBMET01916 | |
| 0.179 | 0.019 | 0.179 | Mediator release inhibitor | 0.126 0.042 DBMET01914 0.133 0.037 DBMET01915 0.134 0.037 DBMET01916 0.127 0.042 DBMET01917 | ||
| 0.169 | 0.008 | 0.169 | Calcium channel L-type blocker | 0.089 0.031 DBMET01914 0.075 0.045 DBMET01915 | ||
| 0.194 | 0.035 | 0.194 | Interleukin 1 antagonist | 0.124 0.083 DBMET01914 | ||
| 0.176 | 0.019 | 0.176 | Photosensitizer | 0.126 0.051 DBMET01914 0.113 0.066 DBMET01915 0.14 0.038 DBMET01916 0.111 0.069 DBMET01917 | ||
| 0.161 | 0.004 | 0.197 | Heat shock protein 90 beta antagonist | 0.189 0.004 DBMET01914 0.197 0.004 DBMET01915 | DBMET01915 | |
| 0.174 | 0.021 | 0.174 | Mucolytic | 0.148 0.033 DBMET01914 0.129 0.046 DBMET01915 0.104 0.072 DBMET01916 0.094 0.086 DBMET01917 | ||
| 0.156 | 0.005 | 0.156 | Acetyl-CoA transferase inhibitor | 0.129 0.008 DBMET01914 0.117 0.009 DBMET01915 0.063 0.028 DBMET01916 0.087 0.018 DBMET01918 0.061 0.03 DBMET01917 0.078 0.021 DBMET01919 | ||
| 0.214 | 0.07 | 0.214 | DNA methylase inhibitor | 0.157 0.112 DBMET01914 | ||
| 0.187 | 0.046 | 0.202 | Interferon gamma antagonist | 0.179 0.051 DBMET01914 0.2 0.041 DBMET01915 0.194 0.043 DBMET01916 0.202 0.04 DBMET01917 | DBMET01917 | |
| 0.18 | 0.041 | 0.261 | NADPH oxidase inhibitor | 0.261 0.018 DBMET01914 0.137 0.064 DBMET01915 | DBMET01914 | |
| 0.161 | 0.029 | 0.161 | Sphingosine 1-phosphate receptor 2 antagonist | 0.159 0.031 DBMET01914 0.159 0.03 DBMET01915 0.122 0.092 DBMET01918 0.127 0.079 DBMET01919 | ||
| 0.197 | 0.067 | 0.441 | Hepatoprotectant | 0.214 0.057 DBMET01914 0.185 0.075 DBMET01915 0.404 0.013 DBMET01916 0.212 0.058 DBMET01918 0.441 0.01 DBMET01917 0.213 0.058 DBMET01919 | DBMET01917 | |
| 0.157 | 0.033 | 0.176 | Expectorant | 0.117 0.052 DBMET01914 0.113 0.056 DBMET01915 0.176 0.026 DBMET01916 0.143 0.038 DBMET01917 | DBMET01916 | |
| 0.157 | 0.032 | 0.157 | GABA receptor agonist | 0.101 0.076 DBMET01914 0.127 0.051 DBMET01915 | ||
| 0.132 | 0.01 | 0.132 | Glycine receptor agonist | 0.11 0.016 DBMET01914 0.103 0.019 DBMET01915 0.077 0.042 DBMET01916 0.075 0.046 DBMET01918 | ||
| 0.142 | 0.02 | 0.142 | ABCA1 expression enhancer | 0.095 0.057 DBMET01914 0.11 0.039 DBMET01915 0.083 0.081 DBMET01918 | ||
| 0.156 | 0.034 | 0.156 | Microtubule formation inhibitor | 0.124 0.057 DBMET01914 0.114 0.068 DBMET01915 0.106 0.08 DBMET01916 0.102 0.087 DBMET01917 | ||
| 0.209 | 0.087 | 0.242 | RNA-directed DNA polymerase inhibitor | 0.235 0.06 DBMET01914 0.208 0.088 DBMET01915 0.217 0.077 DBMET01916 0.242 0.054 DBMET01918 0.191 0.113 DBMET01917 0.219 0.074 DBMET01919 | DBMET01918 | |
| 0.213 | 0.093 | 0.254 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.245 0.079 DBMET01914 0.254 0.077 DBMET01915 | DBMET01915 | |
| 0.161 | 0.043 | 0.181 | Nav1.6 sodium channel blocker | 0.181 0.028 DBMET01914 0.167 0.037 DBMET01915 | DBMET01914 | |
| 0.141 | 0.023 | 0.141 | Anabolic | 0.13 0.03 DBMET01914 0.112 0.048 DBMET01915 0.141 0.023 DBMET01918 0.114 0.046 DBMET01919 | ||
| 0.176 | 0.059 | 0.313 | Interleukin 6 antagonist | 0.161 0.074 DBMET01914 0.165 0.07 DBMET01915 0.313 0.013 DBMET01916 0.259 0.021 DBMET01917 | DBMET01916 | |
| 0.162 | 0.045 | 0.201 | Adenylate cyclase stimulant | 0.152 0.06 DBMET01914 0.201 0.013 DBMET01915 0.143 0.075 DBMET01918 0.141 0.079 DBMET01917 0.175 0.03 DBMET01919 | DBMET01915 | |
| 0.119 | 0.003 | 0.13 | Thyroid hormone alpha antagonist | 0.13 0.003 DBMET01914 0.115 0.003 DBMET01915 0.029 0.005 DBMET01916 0.04 0.004 DBMET01918 0.018 0.009 DBMET01919 | DBMET01914 | |
| 0.136 | 0.023 | 0.136 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.125 0.027 DBMET01914 0.085 0.047 DBMET01915 | ||
| 0.125 | 0.015 | 0.128 | Interferon agonist | 0.128 0.015 DBMET01914 0.072 0.067 DBMET01915 0.125 0.015 DBMET01916 0.12 0.017 DBMET01918 0.08 0.051 DBMET01917 0.078 0.055 DBMET01919 | DBMET01914 | |
| 0.205 | 0.096 | 0.379 | Antiamyloidogenic | 0.248 0.072 DBMET01914 0.379 0.033 DBMET01915 0.243 0.074 DBMET01916 0.321 0.046 DBMET01917 | DBMET01915 | |
| 0.131 | 0.026 | 0.131 | Acetylcholine nicotinic antagonist | 0.074 0.061 DBMET01915 | ||
| 0.135 | 0.033 | 0.168 | Estrogen antagonist | 0.168 0.018 DBMET01914 0.154 0.022 DBMET01915 0.118 0.059 DBMET01916 0.11 0.076 DBMET01918 | DBMET01914 | |
| 0.108 | 0.007 | 0.116 | Potassium channel Kv1.3 blocker | 0.116 0.006 DBMET01914 0.087 0.01 DBMET01915 | DBMET01914 | |
| 0.148 | 0.047 | 0.148 | Ca2+-transporting ATPase inhibitor | 0.145 0.055 DBMET01914 0.133 0.105 DBMET01915 0.134 0.097 DBMET01916 0.129 0.125 DBMET01917 | ||
| 0.105 | 0.004 | 0.105 | Alpha 1L adrenoreceptor antagonist | 0.103 0.004 DBMET01914 0.093 0.005 DBMET01915 0.072 0.011 DBMET01916 0.081 0.007 DBMET01918 0.049 0.047 DBMET01917 0.059 0.023 DBMET01919 | ||
| 0.132 | 0.031 | 0.154 | Nitric-oxide synthase inhibitor | 0.097 0.065 DBMET01914 0.154 0.021 DBMET01915 0.107 0.05 DBMET01918 0.146 0.024 DBMET01919 | DBMET01915 | |
| 0.189 | 0.09 | 0.189 | Antimitotic | |||
| 0.175 | 0.079 | 0.38 | Nitric oxide antagonist | 0.155 0.091 DBMET01914 0.155 0.091 DBMET01915 0.368 0.029 DBMET01916 0.38 0.028 DBMET01917 | DBMET01917 | |
| 0.149 | 0.057 | 0.149 | Cyclooxygenase 1 inhibitor | 0.136 0.066 DBMET01915 0.106 0.094 DBMET01916 | ||
| 0.097 | 0.005 | 0.097 | Retinoid X alpha receptor agonist | 0.08 0.007 DBMET01914 0.092 0.006 DBMET01915 | ||
| 0.184 | 0.094 | 0.21 | Interleukin antagonist | 0.183 0.094 DBMET01914 0.21 0.079 DBMET01915 0.157 0.112 DBMET01916 0.143 0.124 DBMET01917 | DBMET01915 | |
| 0.103 | 0.014 | 0.103 | Peroxisome proliferator-activated receptor gamma antagonist | 0.077 0.038 DBMET01914 0.095 0.018 DBMET01915 | ||
| 0.136 | 0.049 | 0.136 | DNA intercalator | 0.135 0.05 DBMET01914 0.106 0.068 DBMET01916 0.11 0.065 DBMET01918 | ||
| 0.086 | 0.002 | 0.086 | Estrogen-related receptor gamma agonist | 0.078 0.002 DBMET01914 0.085 0.002 DBMET01915 0.024 0.006 DBMET01918 0.022 0.008 DBMET01919 | ||
| 0.094 | 0.012 | 0.094 | Nitric oxide donor | 0.07 0.032 DBMET01916 0.067 0.037 DBMET01917 | ||
| 0.215 | 0.135 | 0.244 | Hypoxia-inducible factor 1 alpha inhibitor | 0.244 0.106 DBMET01914 0.237 0.113 DBMET01915 | DBMET01914 | |
| 0.145 | 0.066 | 0.145 | Toll-Like receptor 9 antagonist | 0.11 0.098 DBMET01914 | ||
| 0.109 | 0.03 | 0.109 | GABA A receptor agonist | 0.079 0.065 DBMET01914 0.084 0.057 DBMET01915 | ||
| 0.157 | 0.079 | 0.245 | Heat shock protein 90 alpha antagonist | 0.245 0.028 DBMET01914 0.221 0.038 DBMET01915 | DBMET01914 | |
| 0.105 | 0.027 | 0.146 | Na+ K+ transporting ATPase inhibitor | 0.109 0.024 DBMET01914 0.081 0.05 DBMET01915 0.146 0.007 DBMET01916 0.113 0.021 DBMET01918 0.123 0.015 DBMET01917 0.085 0.046 DBMET01919 | DBMET01916 | |
| 0.125 | 0.048 | 0.163 | Nav1.4 sodium channel blocker | 0.139 0.039 DBMET01914 0.133 0.042 DBMET01915 0.163 0.029 DBMET01918 0.153 0.033 DBMET01919 | DBMET01918 | |
| 0.135 | 0.059 | 0.155 | Nav1.3 sodium channel blocker | 0.155 0.044 DBMET01914 0.144 0.052 DBMET01915 | DBMET01914 | |
| 0.169 | 0.095 | 0.264 | Amyloid beta aggregation inhibitor | 0.25 0.058 DBMET01914 0.264 0.053 DBMET01915 0.134 0.121 DBMET01916 0.15 0.108 DBMET01917 | DBMET01915 | |
| 0.12 | 0.047 | 0.12 | Butyrylcholinesterase inhibitor | 0.119 0.048 DBMET01914 0.084 0.078 DBMET01915 | ||
| 0.149 | 0.076 | 0.149 | Phospholipase A2 inhibitor | 0.142 0.083 DBMET01914 0.123 0.111 DBMET01915 | ||
| 0.095 | 0.023 | 0.095 | Elastase 1 inhibitor | |||
| 0.1 | 0.028 | 0.1 | Peroxisome proliferator-activated receptor gamma agonist | 0.072 0.047 DBMET01914 0.089 0.035 DBMET01915 | ||
| 0.185 | 0.113 | 0.219 | Platelet antagonist | 0.148 0.147 DBMET01916 0.219 0.089 DBMET01918 0.187 0.111 DBMET01919 | DBMET01918 | |
| 0.122 | 0.052 | 0.231 | Chelator | 0.231 0.019 DBMET01914 0.144 0.038 DBMET01915 0.095 0.084 DBMET01917 | DBMET01914 | |
| 0.143 | 0.074 | 0.143 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.088 | 0.018 | 0.09 | Interferon inducer | 0.089 0.017 DBMET01914 0.09 0.017 DBMET01916 0.085 0.02 DBMET01918 0.064 0.045 DBMET01917 0.062 0.049 DBMET01919 | DBMET01916 | |
| 0.097 | 0.029 | 0.144 | Estrogen receptor alpha antagonist | 0.144 0.013 DBMET01914 0.11 0.022 DBMET01915 | DBMET01914 | |
| 0.127 | 0.06 | 0.14 | Beta amyloid protein antagonist | 0.14 0.048 DBMET01915 0.131 0.056 DBMET01916 0.112 0.075 DBMET01917 | DBMET01915 | |
| 0.16 | 0.094 | 0.16 | DNA methyltransferase I inhibitor | |||
| 0.072 | 0.006 | 0.072 | Acetyl-CoA transferase 1 inhibitor | 0.058 0.01 DBMET01914 0.054 0.013 DBMET01915 0.048 0.019 DBMET01918 0.044 0.024 DBMET01919 | ||
| 0.075 | 0.009 | 0.075 | Retinoid X receptor agonist | 0.068 0.011 DBMET01914 0.074 0.009 DBMET01915 | ||
| 0.102 | 0.037 | 0.125 | ATPase (Vacuolar H+) inhibitor | 0.105 0.033 DBMET01914 0.104 0.034 DBMET01915 0.125 0.017 DBMET01916 0.122 0.018 DBMET01917 | DBMET01916 | |
| 0.142 | 0.078 | 0.331 | Hemostatic | 0.152 0.066 DBMET01914 0.118 0.117 DBMET01915 0.266 0.02 DBMET01916 0.294 0.016 DBMET01918 0.279 0.018 DBMET01917 0.331 0.013 DBMET01919 | DBMET01919 | |
| 0.199 | 0.137 | 0.249 | Tyrosine 3 hydroxylase inhibitor | 0.209 0.121 DBMET01914 0.249 0.069 DBMET01915 | DBMET01915 | |
| 0.198 | 0.136 | 0.21 | Transcription factor STAT3 inhibitor | 0.21 0.121 DBMET01915 | DBMET01915 | |
| 0.094 | 0.034 | 0.094 | Keratolytic | 0.072 0.06 DBMET01915 | ||
| 0.098 | 0.038 | 0.148 | Inducible nitric-oxide synthase inhibitor | 0.135 0.02 DBMET01915 0.088 0.05 DBMET01918 0.148 0.017 DBMET01919 | DBMET01919 | |
| 0.113 | 0.053 | 0.152 | Nav1.1 sodium channel blocker | 0.152 0.032 DBMET01914 0.113 0.053 DBMET01915 | DBMET01914 | |
| 0.151 | 0.094 | 0.151 | Antipruritic | 0.131 0.121 DBMET01914 0.129 0.125 DBMET01915 | ||
| 0.071 | 0.016 | 0.071 | Acetyl-CoA transferase 2 inhibitor | |||
| 0.08 | 0.027 | 0.155 | Beta adrenoreceptor antagonist | 0.097 0.018 DBMET01914 0.155 0.005 DBMET01915 0.067 0.042 DBMET01919 | DBMET01915 | |
| 0.07 | 0.018 | 0.099 | 5 Hydroxytryptamine 1B agonist | 0.082 0.012 DBMET01914 0.099 0.007 DBMET01915 0.064 0.023 DBMET01918 0.08 0.012 DBMET01919 | DBMET01915 | |
| 0.079 | 0.027 | 0.079 | Exportin-1 inhibitor | |||
| 0.072 | 0.021 | 0.074 | Elastase inhibitor | 0.074 0.02 DBMET01918 0.067 0.024 DBMET01919 | DBMET01918 | |
| 0.066 | 0.016 | 0.088 | Squalene epoxidase inhibitor | 0.088 0.007 DBMET01914 0.069 0.014 DBMET01915 0.071 0.013 DBMET01916 0.055 0.026 DBMET01917 | DBMET01914 | |
| 0.052 | 0.003 | 0.078 | Estrogen-related receptor gamma antagonist | 0.078 0.002 DBMET01914 0.065 0.002 DBMET01915 0.032 0.012 DBMET01916 0.05 0.003 DBMET01918 0.039 0.005 DBMET01919 | DBMET01914 | |
| 0.057 | 0.01 | 0.059 | Alpha 1L adrenoreceptor agonist | 0.053 0.013 DBMET01914 0.059 0.009 DBMET01915 0.041 0.035 DBMET01916 0.048 0.02 DBMET01918 0.048 0.019 DBMET01919 | DBMET01915 | |
| 0.113 | 0.066 | 0.113 | Calcium channel (voltage-sensitive) blocker | |||
| 0.109 | 0.063 | 0.18 | Topoisomerase I inhibitor | 0.107 0.064 DBMET01914 0.18 0.032 DBMET01916 0.122 0.054 DBMET01917 | DBMET01916 | |
| 0.059 | 0.014 | 0.059 | Benzodiazepine antagonist | |||
| 0.061 | 0.018 | 0.067 | Leukocyte elastase inhibitor | 0.067 0.015 DBMET01918 0.061 0.018 DBMET01919 | DBMET01918 | |
| 0.069 | 0.026 | 0.084 | Heme oxygenase stimulant | 0.079 0.015 DBMET01914 0.084 0.013 DBMET01915 0.059 0.05 DBMET01916 0.064 0.036 DBMET01918 0.062 0.04 DBMET01917 0.068 0.028 DBMET01919 | DBMET01915 | |
| 0.149 | 0.106 | 0.224 | Platelet adhesion inhibitor | 0.165 0.091 DBMET01916 0.213 0.064 DBMET01918 0.224 0.059 DBMET01917 0.203 0.069 DBMET01919 | DBMET01917 | |
| 0.046 | 0.005 | 0.046 | Elastase 3A inhibitor | |||
| 0.046 | 0.005 | 0.046 | Elastase 2B inhibitor | |||
| 0.046 | 0.005 | 0.046 | Elastase 3B inhibitor | |||
| 0.07 | 0.029 | 0.071 | Calcium channel P-type blocker | 0.071 0.027 DBMET01914 0.063 0.047 DBMET01915 | DBMET01914 | |
| 0.107 | 0.07 | 0.182 | Monophenol monooxygenase inhibitor | 0.102 0.075 DBMET01914 0.154 0.045 DBMET01915 0.182 0.037 DBMET01916 0.132 0.055 DBMET01917 | DBMET01916 | |
| 0.202 | 0.166 | 0.216 | Caspase 3 stimulant | 0.216 0.148 DBMET01916 0.205 0.162 DBMET01917 | DBMET01916 | |
| 0.087 | 0.051 | 0.087 | 3C-Like protease (SARS coronavirus) inhibitor | 0.081 0.065 DBMET01914 | ||
| 0.097 | 0.063 | 0.219 | Sphingomyelinase inhibitor | 0.138 0.03 DBMET01914 0.102 0.058 DBMET01915 0.219 0.006 DBMET01916 0.158 0.021 DBMET01917 | DBMET01916 | |
| 0.063 | 0.03 | 0.065 | Ryanodine receptor antagonist | 0.065 0.025 DBMET01915 | DBMET01915 | |
| 0.042 | 0.011 | 0.047 | Cholesterol ester transfer protein antagonist | 0.047 0.008 DBMET01914 0.037 0.016 DBMET01918 | DBMET01914 | |
| 0.058 | 0.027 | 0.058 | Peroxisome proliferator-activated receptor alpha agonist | 0.052 0.031 DBMET01915 | ||
| 0.045 | 0.015 | 0.062 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | 0.062 0.007 DBMET01914 0.034 0.032 DBMET01916 0.033 0.032 DBMET01918 | DBMET01914 | |
| 0.114 | 0.084 | 0.114 | Acetylcholinesterase inhibitor | 0.111 0.088 DBMET01914 | ||
| 0.065 | 0.036 | 0.065 | Transcription factor AP-1 inhibitor | |||
| 0.111 | 0.082 | 0.111 | Cholinergic antagonist | |||
| 0.032 | 0.004 | 0.046 | Thyroid hormone alpha agonist | 0.037 0.003 DBMET01914 0.046 0.003 DBMET01915 0.019 0.008 DBMET01916 0.023 0.005 DBMET01918 0.017 0.01 DBMET01917 0.021 0.006 DBMET01919 | DBMET01915 | |
| 0.05 | 0.022 | 0.089 | Geranyltranstransferase inhibitor | 0.089 0.004 DBMET01914 0.063 0.011 DBMET01915 | DBMET01914 | |
| 0.095 | 0.068 | 0.142 | 5-Lipoxygenase inhibitor | 0.142 0.041 DBMET01914 0.116 0.052 DBMET01915 | DBMET01914 | |
| 0.04 | 0.014 | 0.04 | Benzodiazepine receptor peripheral-type antagonist | |||
| 0.035 | 0.009 | 0.066 | Thyroid hormone agonist | 0.041 0.006 DBMET01914 0.066 0.004 DBMET01915 0.043 0.005 DBMET01918 0.04 0.006 DBMET01919 | DBMET01915 | |
| 0.07 | 0.045 | 0.07 | Neuronal nicotinic receptor antagonist | 0.058 0.057 DBMET01915 | ||
| 0.082 | 0.058 | 0.082 | Glutathione S-transferase inhibitor | 0.082 0.058 DBMET01915 | ||
| 0.225 | 0.202 | 0.556 | Antibacterial | 0.274 0.156 DBMET01914 0.259 0.168 DBMET01915 0.495 0.042 DBMET01916 0.299 0.136 DBMET01918 0.556 0.027 DBMET01917 0.315 0.124 DBMET01919 | DBMET01917 | |
| 0.032 | 0.01 | 0.032 | Retinoid X gamma receptor antagonist | 0.032 0.01 DBMET01914 0.03 0.012 DBMET01915 0.026 0.02 DBMET01918 | ||
| 0.061 | 0.038 | 0.091 | Bcl-xL inhibitor | 0.091 0.008 DBMET01914 | DBMET01914 | |
| 0.039 | 0.018 | 0.039 | Peroxisome proliferator-activated receptor delta agonist | 0.037 0.019 DBMET01915 | ||
| 0.041 | 0.021 | 0.049 | Retinoid X receptor antagonist | 0.049 0.013 DBMET01914 0.042 0.021 DBMET01915 | DBMET01914 | |
| 0.053 | 0.034 | 0.106 | Estrogen agonist | 0.064 0.028 DBMET01914 0.055 0.032 DBMET01915 0.042 0.041 DBMET01916 0.106 0.016 DBMET01918 0.077 0.024 DBMET01919 | DBMET01918 | |
| 0.081 | 0.062 | 0.086 | T cell inhibitor | 0.086 0.046 DBMET01916 | DBMET01916 | |
| 0.037 | 0.019 | 0.042 | Retinoid X alpha receptor antagonist | 0.042 0.013 DBMET01914 0.036 0.02 DBMET01915 | DBMET01914 | |
| 0.037 | 0.02 | 0.037 | Purinergic P2X3 antagonist | 0.037 0.02 DBMET01914 0.035 0.022 DBMET01915 | ||
| 0.022 | 0.005 | 0.022 | Vitamin D receptor agonist | 0.018 0.008 DBMET01914 0.016 0.013 DBMET01915 0.016 0.013 DBMET01916 | ||
| 0.094 | 0.078 | 0.106 | Folate antagonist | 0.106 0.055 DBMET01915 0.092 0.083 DBMET01917 | DBMET01915 | |
| 0.075 | 0.059 | 0.077 | Macrophage migration inhibitory factor inhibitor | 0.077 0.055 DBMET01914 0.07 0.066 DBMET01915 | DBMET01914 | |
| 0.036 | 0.021 | 0.036 | HMG CoA reductase inhibitor | |||
| 0.08 | 0.067 | 0.114 | Ornithine decarboxylase inhibitor | 0.087 0.059 DBMET01914 0.114 0.03 DBMET01915 0.085 0.061 DBMET01917 | DBMET01915 | |
| 0.102 | 0.089 | 0.102 | Acetylcholine antagonist | |||
| 0.062 | 0.049 | 0.134 | Beta 3 adrenoreceptor antagonist | 0.099 0.015 DBMET01914 0.134 0.007 DBMET01915 0.062 0.05 DBMET01918 0.068 0.037 DBMET01919 | DBMET01915 | |
| 0.092 | 0.079 | 0.12 | Estrogen receptor beta antagonist | 0.12 0.031 DBMET01914 0.12 0.032 DBMET01915 | DBMET01915 | |
| 0.027 | 0.015 | 0.034 | Vanilloid 2 agonist | 0.025 0.017 DBMET01914 0.028 0.012 DBMET01915 0.034 0.006 DBMET01916 0.03 0.01 DBMET01917 | DBMET01916 | |
| 0.046 | 0.034 | 0.046 | Microtubule stabilization | |||
| 0.022 | 0.012 | 0.022 | Retinoid X beta receptor antagonist | 0.021 0.012 DBMET01914 | ||
| 0.055 | 0.046 | 0.06 | Sphingosine 1-phosphate receptor 3 antagonist | 0.06 0.038 DBMET01914 | DBMET01914 | |
| 0.085 | 0.075 | 0.109 | Glutamate release inhibitor | 0.105 0.035 DBMET01914 0.109 0.032 DBMET01915 | DBMET01915 | |
| 0.031 | 0.024 | 0.038 | Estrogen-related receptor alpha antagonist | 0.036 0.019 DBMET01914 0.038 0.019 DBMET01915 | DBMET01915 | |
| 0.13 | 0.123 | 0.142 | Heat shock protein 70 antagonist | 0.142 0.069 DBMET01914 0.134 0.099 DBMET01915 0.138 0.082 DBMET01916 | DBMET01914 | |
| 0.066 | 0.059 | 0.066 | Cathepsin G inhibitor | 0.064 0.063 DBMET01918 | ||
| 0.051 | 0.045 | 0.127 | Beta 1 adrenoreceptor antagonist | 0.063 0.032 DBMET01914 0.127 0.006 DBMET01915 | DBMET01915 | |
| 0.076 | 0.071 | 0.076 | Antineoplastic alkaloid | |||
| 0.048 | 0.044 | 0.057 | Glucose-6-phosphate translocase inhibitor | 0.057 0.028 DBMET01916 | DBMET01916 | |
| 0.171 | 0.167 | 0.293 | DNA synthesis inhibitor | 0.212 0.106 DBMET01914 0.276 0.053 DBMET01916 0.293 0.046 DBMET01917 | DBMET01917 | |
| 0.093 | 0.09 | 0.11 | GABA C receptor antagonist | 0.11 0.063 DBMET01914 0.107 0.067 DBMET01915 0.104 0.072 DBMET01918 0.104 0.072 DBMET01919 | DBMET01914 | |
| 0.086 | 0.083 | 0.106 | Bile acid receptor antagonist | 0.093 0.065 DBMET01914 0.106 0.038 DBMET01915 0.088 0.08 DBMET01918 | DBMET01915 | |
| 0.076 | 0.074 | 0.099 | Histamine H2 receptor antagonist | 0.084 0.057 DBMET01914 0.099 0.035 DBMET01915 | DBMET01915 | |
| 0.067 | 0.064 | 0.078 | CYP2A6 inhibitor | 0.078 0.05 DBMET01914 0.074 0.054 DBMET01915 | DBMET01914 | |
| 0.07 | 0.068 | 0.095 | GABA B receptor agonist | 0.077 0.047 DBMET01914 0.095 0.021 DBMET01915 | DBMET01915 | |
| 0.014 | 0.012 | 0.029 | Calcium-sensing receptor antagonist | 0.014 0.011 DBMET01914 0.029 0.006 DBMET01915 | DBMET01915 | |
| 0.038 | 0.036 | 0.048 | Sphingosine 1-phosphate receptor 1 agonist | 0.048 0.022 DBMET01915 | DBMET01915 | |
| 0.053 | 0.052 | 0.053 | Pregnane X receptor antagonist | |||
| 0.042 | 0.042 | 0.054 | Parathyroid hormone antagonist | 0.042 0.04 DBMET01914 0.054 0.016 DBMET01915 | DBMET01915 | |
| 0.084 | 0.085 | 0.206 | Toll-Like receptor 3 antagonist | 0.095 0.058 DBMET01914 0.206 0.005 DBMET01915 0.132 0.022 DBMET01917 0.186 0.008 DBMET01919 | DBMET01915 | |
| 0.007 | 0.008 | 0.029 | Thyroid hormone beta agonist | 0.009 0.006 DBMET01914 0.029 0.003 DBMET01915 | DBMET01915 | |
| 0.092 | 0.094 | 0.153 | Topoisomerase II inhibitor | 0.116 0.071 DBMET01914 0.153 0.048 DBMET01916 0.103 0.083 DBMET01917 | DBMET01916 | |
| 0.029 | 0.031 | 0.037 | Glutamate (mGluR3) agonist | 0.037 0.013 DBMET01915 | DBMET01915 | |
| 0.078 | 0.081 | 0.134 | Triose-phosphate isomerase inhibitor | 0.134 0.025 DBMET01918 0.118 0.033 DBMET01919 | DBMET01918 | |
| 0.202 | 0.205 | 0.213 | GABA C receptor rho-3 antagonist | 0.213 0.192 DBMET01915 | DBMET01915 | |
| 0.02 | 0.023 | 0.021 | Vitamin D receptor antagonist | 0.02 0.019 DBMET01914 0.021 0.018 DBMET01915 | DBMET01915 | |
| 0.056 | 0.062 | 0.075 | Phosphodiesterase 1C inhibitor | 0.075 0.024 DBMET01914 | DBMET01914 | |
| 0.063 | 0.07 | 0.155 | CDC25A inhibitor | 0.066 0.064 DBMET01914 0.155 0.012 DBMET01918 0.134 0.015 DBMET01919 | DBMET01918 | |
| 0.018 | 0.026 | 0.026 | Dopamine D1 agonist | 0.022 0.017 DBMET01914 0.023 0.015 DBMET01915 0.023 0.015 DBMET01918 0.026 0.012 DBMET01919 | DBMET01919 | |
| 0.043 | 0.053 | 0.055 | Acyl-CoA dehydrogenase inhibitor | 0.055 0.037 DBMET01914 | DBMET01914 | |
| 0.095 | 0.107 | 0.119 | Aldehyde dehydrogenase inhibitor | 0.108 0.085 DBMET01914 0.119 0.071 DBMET01916 0.116 0.076 DBMET01917 | DBMET01916 | |
| 0.032 | 0.044 | 0.043 | GABA uptake inhibitor | 0.043 0.022 DBMET01914 | DBMET01914 | |
| 0.126 | 0.138 | 0.514 | Angiogenesis stimulant | 0.208 0.09 DBMET01915 0.416 0.019 DBMET01916 0.3 0.049 DBMET01918 0.514 0.011 DBMET01917 0.316 0.043 DBMET01919 | DBMET01917 | |
| 0.028 | 0.04 | 0.036 | Farnesoid X receptor agonist | 0.036 0.028 DBMET01918 | DBMET01918 | |
| 0.089 | 0.103 | 0.127 | MAO inhibitor | 0.126 0.071 DBMET01914 0.127 0.071 DBMET01915 | DBMET01915 | |
| 0.027 | 0.042 | 0.032 | Melatonin receptor 1A agonist | 0.032 0.027 DBMET01915 | DBMET01915 | |
| 0.021 | 0.036 | 0.038 | Sphingosine 1-phosphate receptor 3 agonist | 0.03 0.027 DBMET01914 0.038 0.023 DBMET01915 | DBMET01915 | |
| 0.171 | 0.186 | 0.19 | Transcription factor STAT inhibitor | 0.19 0.153 DBMET01915 | DBMET01915 | |
| 0.026 | 0.044 | 0.045 | Estrogen-related receptor beta antagonist | 0.045 0.007 DBMET01914 | DBMET01914 | |
| 0.01 | 0.028 | 0.035 | Ileal bile acid transport inhibitor | 0.035 0.004 DBMET01916 0.021 0.009 DBMET01917 | DBMET01916 | |
| 0.146 | 0.165 | 0.408 | Tumour necrosis factor alpha release inhibitor | 0.374 0.032 DBMET01916 0.408 0.026 DBMET01917 | DBMET01917 | |
| 0.033 | 0.053 | 0.043 | Sphingosine 1-phosphate receptor agonist | 0.043 0.033 DBMET01915 | DBMET01915 | |
| 0.055 | 0.074 | 0.111 | Potassium channel large-conductance Ca-activated activator | 0.111 0.019 DBMET01915 | DBMET01915 | |
| 0.153 | 0.174 | 0.186 | ErbB-1 antagonist | 0.186 0.107 DBMET01914 | DBMET01914 | |
| 0.045 | 0.067 | 0.073 | TRPA1 antagonist | 0.073 0.03 DBMET01915 | DBMET01915 | |
| 0.036 | 0.059 | 0.12 | Beta 2 adrenoreceptor antagonist | 0.059 0.024 DBMET01914 0.12 0.006 DBMET01915 0.051 0.035 DBMET01919 | DBMET01915 | |
| 0.074 | 0.098 | 0.123 | Thioredoxin inhibitor | 0.123 0.029 DBMET01916 0.122 0.03 DBMET01917 | DBMET01916 | |
| 0.083 | 0.107 | 0.093 | Adenylate kinase inhibitor | 0.093 0.08 DBMET01914 | DBMET01914 | |
| 0.036 | 0.062 | 0.065 | Cholesterol esterase inhibitor | 0.065 0.013 DBMET01914 | DBMET01914 | |
| 0.036 | 0.062 | 0.081 | Protein 50S ribosomal subunit inhibitor | 0.081 0.019 DBMET01916 0.074 0.022 DBMET01917 | DBMET01916 | |
| 0.055 | 0.082 | 0.091 | Topoisomerase II alpha inhibitor | 0.091 0.045 DBMET01914 0.082 0.052 DBMET01916 | DBMET01914 | |
| 0.129 | 0.158 | 0.181 | Phospholipase C inhibitor | 0.179 0.062 DBMET01914 0.156 0.094 DBMET01915 0.181 0.059 DBMET01918 0.15 0.105 DBMET01919 | DBMET01918 | |
| 0.049 | 0.079 | 0.061 | Lipocortins synthesis agonist | 0.061 0.033 DBMET01916 0.06 0.036 DBMET01917 | DBMET01916 | |
| 0.073 | 0.104 | 0.136 | UDP-glucose 4-epimerase inhibitor | 0.084 0.083 DBMET01914 0.136 0.034 DBMET01916 0.132 0.036 DBMET01917 | DBMET01916 | |
| 0.102 | 0.132 | 0.223 | Diuretic | 0.117 0.108 DBMET01916 0.223 0.037 DBMET01918 0.177 0.056 DBMET01919 | DBMET01918 | |
| 0.089 | 0.121 | 0.123 | Bone formation stimulant | 0.123 0.083 DBMET01914 | DBMET01914 | |
| 0.191 | 0.223 | 0.295 | 15-Lipoxygenase inhibitor | 0.295 0.135 DBMET01914 0.288 0.139 DBMET01915 | DBMET01914 | |
| 0.02 | 0.054 | 0.027 | Toll-Like receptor 4 agonist | 0.026 0.018 DBMET01916 0.026 0.021 DBMET01918 0.027 0.016 DBMET01917 0.027 0.017 DBMET01919 | DBMET01919 | |
| 0.038 | 0.072 | 0.063 | HIV-1 integrase (Strand Transfer) inhibitor | 0.063 0.039 DBMET01918 0.062 0.04 DBMET01919 | DBMET01918 | |
| 0.08 | 0.116 | 0.181 | Toll-Like receptor 4 antagonist | 0.099 0.071 DBMET01914 0.176 0.01 DBMET01916 0.181 0.009 DBMET01917 | DBMET01917 | |
| 0.199 | 0.239 | 0.238 | Analgesic | 0.238 0.193 DBMET01915 | DBMET01915 | |
| 0.086 | 0.126 | 0.097 | Acetylcholine release stimulant | 0.097 0.094 DBMET01918 | DBMET01918 | |
| 0.034 | 0.075 | 0.059 | H+/K+-transporting ATPase inhibitor | 0.059 0.026 DBMET01918 0.052 0.035 DBMET01919 | DBMET01918 | |
| 0.059 | 0.1 | 0.119 | Antiadrenergic | 0.087 0.065 DBMET01914 0.119 0.046 DBMET01915 | DBMET01915 | |
| 0.067 | 0.109 | 0.147 | Transcription factor NF kappa B stimulant | 0.127 0.022 DBMET01916 0.147 0.016 DBMET01917 | DBMET01917 | |
| 0.023 | 0.066 | 0.05 | Oxytocin agonist | 0.05 0.024 DBMET01914 0.049 0.024 DBMET01915 | DBMET01914 | |
| 0.057 | 0.102 | 0.099 | MAO B inhibitor | 0.099 0.06 DBMET01914 0.079 0.077 DBMET01915 | DBMET01914 | |
| 0.056 | 0.102 | 0.113 | Adrenaline antagonist | 0.084 0.065 DBMET01914 0.113 0.046 DBMET01915 | DBMET01915 | |
| 0.059 | 0.105 | 0.161 | Potassium channel (Ca-activated) activator | 0.161 0.025 DBMET01915 | DBMET01915 | |
| 0.045 | 0.091 | 0.17 | Antineoplastic antibiotic | 0.15 0.031 DBMET01916 0.17 0.027 DBMET01917 | DBMET01917 | |
| 0.144 | 0.193 | 0.2 | 5 Hydroxytryptamine release stimulant | 0.2 0.121 DBMET01915 0.179 0.142 DBMET01917 | DBMET01915 | |
| 0.025 | 0.075 | 0.05 | Guanylate cyclase inhibitor | 0.05 0.021 DBMET01918 | DBMET01918 | |
| 0.067 | 0.118 | 0.106 | Alpha 2c adrenoreceptor antagonist | 0.106 0.061 DBMET01914 0.097 0.069 DBMET01915 | DBMET01914 | |
| 0.046 | 0.097 | 0.083 | Bcl2 antagonist | 0.083 0.029 DBMET01914 | DBMET01914 | |
| 0.045 | 0.1 | 0.058 | Phosphodiesterase 1A inhibitor | 0.058 0.046 DBMET01914 | DBMET01914 | |
| 0.081 | 0.137 | 0.106 | Electron transport complex I inhibitor | 0.106 0.07 DBMET01914 | DBMET01914 | |
| 0.015 | 0.071 | 0.022 | ICAM 1 antagonist | 0.022 0.02 DBMET01915 | DBMET01915 | |
| 0.08 | 0.139 | 0.119 | Alpha-N-acetylglucosaminidase inhibitor | 0.104 0.095 DBMET01914 0.103 0.097 DBMET01915 0.119 0.079 DBMET01917 | DBMET01917 | |
| 0.036 | 0.095 | 0.081 | Dopamine agonist | 0.081 0.037 DBMET01915 0.061 0.051 DBMET01919 | DBMET01915 | |
| 0.036 | 0.099 | 0.09 | Toll-Like receptor 7 antagonist | 0.09 0.029 DBMET01915 | DBMET01915 | |
| 0.045 | 0.111 | 0.065 | Potassium channel (ATP-sensitive) blocker | 0.065 0.051 DBMET01914 | DBMET01914 | |
| 0.051 | 0.12 | 0.095 | Histamine N-methyltransferase inhibitor | 0.095 0.05 DBMET01914 | DBMET01914 | |
| 0.068 | 0.137 | 0.101 | 5 Hydroxytryptamine 2B antagonist | 0.101 0.083 DBMET01914 | DBMET01914 | |
| 0.073 | 0.143 | 0.107 | Glutamate (mGluR7) agonist | 0.107 0.047 DBMET01915 | DBMET01915 | |
| 0.036 | 0.106 | 0.051 | Vanilloid 2 antagonist | 0.051 0.038 DBMET01915 | DBMET01915 | |
| 0.083 | 0.154 | 0.174 | Thrombolytic | 0.174 0.065 DBMET01916 0.167 0.07 DBMET01917 | DBMET01916 | |
| 0.015 | 0.088 | 0.033 | 1,3-Beta-glucan synthase inhibitor | 0.028 0.019 DBMET01916 0.033 0.008 DBMET01918 0.029 0.019 DBMET01917 0.033 0.008 DBMET01919 | DBMET01919 | |
| 0.06 | 0.134 | 0.107 | Protein-tyrosine phosphatase 1B inhibitor | 0.107 0.072 DBMET01918 0.095 0.083 DBMET01919 | DBMET01918 | |
| 0.035 | 0.109 | 0.066 | Bombesin 1 receptor agonist | 0.066 0.035 DBMET01915 0.054 0.049 DBMET01919 | DBMET01915 | |
| 0.107 | 0.183 | 0.133 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.128 0.12 DBMET01914 0.133 0.109 DBMET01915 | DBMET01915 | |
| 0.036 | 0.112 | 0.06 | HIV-1 integrase (3'-Processing) inhibitor | 0.056 0.052 DBMET01918 0.06 0.047 DBMET01919 | DBMET01919 | |
| 0.013 | 0.09 | 0.072 | Sodium/glucose cotransporter inhibitor | 0.072 0.004 DBMET01916 0.042 0.006 DBMET01917 | DBMET01916 | |
| 0.032 | 0.109 | 0.054 | CXC chemokine 1 receptor antagonist | 0.054 0.031 DBMET01914 | DBMET01914 | |
| 0.035 | 0.113 | 0.114 | Adrenaline uptake inhibitor | 0.114 0.015 DBMET01915 | DBMET01915 | |
| 0.048 | 0.127 | 0.073 | Beta 2 adrenoreceptor agonist | 0.061 0.045 DBMET01914 0.073 0.015 DBMET01915 | DBMET01915 | |
| 0.026 | 0.107 | 0.037 | Vanilloid 3 antagonist | 0.037 0.031 DBMET01914 | DBMET01914 | |
| 0.141 | 0.222 | 0.288 | 12-Lipoxygenase inhibitor | 0.288 0.086 DBMET01914 0.244 0.112 DBMET01915 | DBMET01914 | |
| 0.029 | 0.11 | 0.049 | Glucose-6-phosphate isomerase inhibitor | 0.049 0.032 DBMET01916 0.044 0.041 DBMET01917 | DBMET01916 | |
| 0.048 | 0.13 | 0.09 | MAO A inhibitor | 0.09 0.071 DBMET01915 | DBMET01915 | |
| 0.091 | 0.174 | 0.164 | Mannose-6-phosphate isomerase inhibitor | 0.164 0.054 DBMET01914 0.161 0.055 DBMET01916 0.114 0.112 DBMET01917 | DBMET01914 | |
| 0.15 | 0.234 | 0.331 | Immunomodulator | 0.331 0.067 DBMET01916 0.213 0.149 DBMET01917 | DBMET01916 | |
| 0.062 | 0.146 | 0.124 | Alpha 2b adrenoreceptor antagonist | 0.124 0.055 DBMET01914 0.117 0.061 DBMET01915 | DBMET01914 | |
| 0.064 | 0.149 | 0.112 | Xanthine oxidase inhibitor | 0.112 0.052 DBMET01916 | DBMET01916 | |
| 0.113 | 0.199 | 0.149 | Succinate dehydrogenase inhibitor | 0.149 0.114 DBMET01914 0.14 0.133 DBMET01915 | DBMET01914 | |
| 0.029 | 0.116 | 0.081 | 5 Hydroxytryptamine 2A agonist | 0.081 0.027 DBMET01915 | DBMET01915 | |
| 0.01 | 0.097 | 0.083 | Sodium/glucose cotransporter 2 inhibitor | 0.083 0.004 DBMET01916 0.043 0.008 DBMET01917 | DBMET01916 | |
| 0.079 | 0.168 | 0.104 | Interleukin 8 antagonist | 0.104 0.088 DBMET01915 | DBMET01915 | |
| 0.036 | 0.126 | 0.06 | Phosphodiesterase 1B inhibitor | 0.06 0.042 DBMET01914 | DBMET01914 | |
| 0.032 | 0.124 | 0.056 | Beta adrenoreceptor agonist | 0.056 0.01 DBMET01915 | DBMET01915 | |
| 0.089 | 0.182 | 0.141 | DNA repair enzyme inhibitor | 0.141 0.041 DBMET01916 0.13 0.055 DBMET01917 | DBMET01916 | |
| 0.061 | 0.159 | 0.126 | DNA polymerase I inhibitor | 0.126 0.064 DBMET01914 0.109 0.077 DBMET01915 0.107 0.079 DBMET01916 | DBMET01914 | |
| 0.145 | 0.247 | 0.26 | Calpain 2 inhibitor | 0.246 0.152 DBMET01914 0.26 0.142 DBMET01915 | DBMET01915 | |
| 0.09 | 0.192 | 0.143 | Insulin secretagoues | 0.143 0.082 DBMET01916 0.138 0.087 DBMET01917 | DBMET01916 | |
| 0.038 | 0.142 | 0.097 | Phospholipase D inhibitor | 0.083 0.03 DBMET01918 0.097 0.016 DBMET01919 | DBMET01919 | |
| 0.043 | 0.152 | 0.185 | Adrenaline agonist | 0.083 0.053 DBMET01914 0.185 0.008 DBMET01915 | DBMET01915 | |
| 0.031 | 0.144 | 0.061 | Dopamine D1 antagonist | 0.061 0.049 DBMET01914 | DBMET01914 | |
| 0.034 | 0.148 | 0.065 | NMDA receptor agonist | 0.065 0.041 DBMET01919 | DBMET01919 | |
| 0.059 | 0.174 | 0.308 | Amylase inhibitor | 0.127 0.077 DBMET01914 0.308 0.017 DBMET01916 0.254 0.027 DBMET01917 | DBMET01916 | |
| 0.133 | 0.249 | 0.337 | Peptidyltransferase inhibitor | 0.172 0.142 DBMET01914 0.252 0.05 DBMET01915 0.306 0.022 DBMET01916 0.337 0.014 DBMET01917 0.174 0.139 DBMET01919 | DBMET01917 | |
| 0.077 | 0.195 | 0.207 | Protein-tyrosine phosphatase inhibitor | 0.207 0.044 DBMET01918 0.181 0.055 DBMET01919 | DBMET01918 | |
| 0.05 | 0.171 | 0.088 | Uric acid excretion stimulant | 0.088 0.068 DBMET01916 | DBMET01916 | |
| 0.043 | 0.164 | 0.095 | Aminopeptidase B inhibitor | 0.095 0.068 DBMET01918 | DBMET01918 | |
| 0.008 | 0.131 | 0.024 | Beta 1 adrenoreceptor agonist | 0.024 0.013 DBMET01915 | DBMET01915 | |
| 0.156 | 0.282 | 0.323 | Interleukin 2 agonist | 0.243 0.127 DBMET01915 0.323 0.059 DBMET01916 0.32 0.061 DBMET01917 | DBMET01916 | |
| 0.01 | 0.142 | 0.034 | Protein 30S ribosomal subunit inhibitor | 0.032 0.012 DBMET01916 0.034 0.011 DBMET01917 | DBMET01917 | |
| 0.062 | 0.194 | 0.098 | Interleukin 12 antagonist | 0.085 0.084 DBMET01915 0.094 0.064 DBMET01916 0.098 0.058 DBMET01917 | DBMET01917 | |
| 0.052 | 0.189 | 0.099 | NADH dehydrogenase inhibitor | 0.099 0.045 DBMET01916 0.09 0.056 DBMET01917 | DBMET01916 | |
| 0.151 | 0.29 | 0.209 | 5 Hydroxytryptamine uptake stimulant | 0.209 0.134 DBMET01915 | DBMET01915 | |
| 0.016 | 0.161 | 0.061 | 5 Hydroxytryptamine uptake inhibitor | 0.061 0.046 DBMET01915 | DBMET01915 | |
| 0.005 | 0.15 | 0.214 | Cholecystokinin A agonist | 0.213 0.003 DBMET01918 0.214 0.003 DBMET01919 | DBMET01919 | |
| 0.142 | 0.288 | 0.419 | Antiobesity | 0.29 0.123 DBMET01916 0.419 0.059 DBMET01918 0.276 0.134 DBMET01917 0.396 0.067 DBMET01919 | DBMET01918 | |
| 0.112 | 0.266 | 0.222 | Superoxide dismutase inhibitor | 0.2 0.117 DBMET01915 0.217 0.1 DBMET01918 0.222 0.096 DBMET01919 | DBMET01919 | |
| 0.052 | 0.208 | 0.117 | Beta glucuronidase inhibitor | 0.117 0.049 DBMET01916 | DBMET01916 | |
| 0.024 | 0.181 | 0.093 | Alpha adrenoreceptor agonist | 0.093 0.031 DBMET01915 | DBMET01915 | |
| 0.024 | 0.186 | 0.066 | Lipase inhibitor | 0.066 0.058 DBMET01914 | DBMET01914 | |
| 0.042 | 0.207 | 0.094 | Creatine kinase inhibitor | 0.094 0.067 DBMET01914 | DBMET01914 | |
| 0.07 | 0.236 | 0.149 | Cell wall synthesis inhibitor | 0.128 0.089 DBMET01918 0.149 0.067 DBMET01919 | DBMET01919 | |
| 0.021 | 0.186 | 0.054 | Alpha 2 adrenoreceptor agonist | 0.054 0.051 DBMET01915 | DBMET01915 | |
| 0.02 | 0.187 | 0.083 | Alpha-mannosidase inhibitor | 0.083 0.01 DBMET01916 0.077 0.013 DBMET01917 | DBMET01916 | |
| 0.005 | 0.173 | 0.254 | Cholecystokinin agonist | 0.254 0.003 DBMET01918 0.254 0.003 DBMET01919 | DBMET01919 | |
| 0.038 | 0.208 | 0.107 | Urease inhibitor | 0.107 0.059 DBMET01914 0.09 0.079 DBMET01915 | DBMET01914 | |
| 0.018 | 0.203 | 0.063 | Antibiotic Aminoglycoside-like | 0.061 0.008 DBMET01916 0.063 0.008 DBMET01917 | DBMET01917 | |
| 0.162 | 0.355 | 0.531 | Calcium channel L-type activator | 0.292 0.164 DBMET01914 0.531 0.018 DBMET01915 0.424 0.066 DBMET01917 0.472 0.04 DBMET01919 | DBMET01915 | |
| 0.055 | 0.254 | 0.191 | Mcl-1 antagonist | 0.191 0.06 DBMET01914 | DBMET01914 | |
| 0.013 | 0.213 | 0.068 | Mannosidase inhibitor | 0.068 0.013 DBMET01916 0.064 0.015 DBMET01917 | DBMET01916 | |
| 0.098 | 0.302 | 0.143 | Neurotensin receptor agonist | 0.143 0.119 DBMET01915 | DBMET01915 | |
| 0.014 | 0.221 | 0.041 | Purinergic P2Y2 antagonist | 0.041 0.015 DBMET01918 0.039 0.017 DBMET01919 | DBMET01918 | |
| 0.017 | 0.224 | 0.318 | Selectin antagonist | 0.318 0.005 DBMET01916 0.061 0.048 DBMET01918 0.316 0.005 DBMET01917 0.084 0.035 DBMET01919 | DBMET01916 | |
| 0.098 | 0.307 | 0.199 | Catenin beta inhibitor | 0.199 0.033 DBMET01914 | DBMET01914 | |
| 0.03 | 0.24 | 0.082 | Glycine receptor antagonist | 0.082 0.053 DBMET01916 0.073 0.069 DBMET01918 0.075 0.066 DBMET01917 | DBMET01916 | |
| 0.032 | 0.244 | 0.082 | Adenine nucleotide translocase inhibitor | 0.082 0.008 DBMET01916 0.078 0.01 DBMET01917 | DBMET01916 | |
| 0.014 | 0.237 | 0.42 | Cholecystokinin B agonist | 0.406 0.003 DBMET01918 0.42 0.003 DBMET01919 | DBMET01919 | |
| 0.014 | 0.236 | 0.056 | Alpha 1 adrenoreceptor agonist | 0.056 0.042 DBMET01915 | DBMET01915 | |
| 0.115 | 0.344 | 0.192 | Insulysin inhibitor | 0.192 0.169 DBMET01914 | DBMET01914 | |
| 0.049 | 0.295 | 0.147 | Cell adhesion inhibitor | 0.108 0.076 DBMET01916 0.147 0.049 DBMET01917 | DBMET01917 | |
| 0.045 | 0.314 | 0.09 | mTOR complex 1 inhibitor | 0.09 0.087 DBMET01915 | DBMET01915 | |
| 0.044 | 0.345 | 0.246 | Dual specificity phosphatase inhibitor | 0.246 0.039 DBMET01918 0.183 0.065 DBMET01919 | DBMET01918 | |
| 0.038 | 0.339 | 0.081 | mTOR complex 2 inhibitor | 0.081 0.066 DBMET01915 | DBMET01915 | |
| 0.057 | 0.37 | 0.181 | Streptokinase A inhibitor | 0.177 0.149 DBMET01914 0.181 0.145 DBMET01915 | DBMET01915 | |
| 0.035 | 0.388 | 0.209 | Anticoagulant | 0.194 0.055 DBMET01918 0.209 0.05 DBMET01919 | DBMET01919 | |
| 0.028 | 0.383 | 0.166 | Multidrug resistance-associated protein 1 inhibitor | 0.166 0.019 DBMET01918 0.135 0.035 DBMET01919 | DBMET01918 | |
| 0.051 | 0.434 | 0.447 | Alpha-glucosidase inhibitor | 0.338 0.142 DBMET01916 0.447 0.097 DBMET01917 | DBMET01917 | |
| 0.03 | 0.434 | 0.222 | Dual specificity phosphatase 3 inhibitor | 0.222 0.05 DBMET01918 0.191 0.066 DBMET01919 | DBMET01918 | |
| 0.017 | 0.463 | 0.081 | Histone deacetylase stimulant | 0.081 0.043 DBMET01916 | DBMET01916 | |
| 0.017 | 0.463 | 0.081 | Histone deacetylase SIRT1 stimulant | 0.081 0.043 DBMET01916 | DBMET01916 | |
| 0.004 | 0.481 | 0.07 | Cholecystokinin antagonist | 0.07 0.014 DBMET01918 0.067 0.015 DBMET01919 | DBMET01918 | |
| 0.003 | 0.493 | 0.097 | Cholecystokinin A antagonist | 0.097 0.009 DBMET01918 0.089 0.011 DBMET01919 | DBMET01918 | |
| 0.003 | 0.496 | 0.045 | Cholecystokinin B antagonist | 0.045 0.011 DBMET01918 0.043 0.012 DBMET01919 | DBMET01918 | |
| 0.058 | 0.606 | 0.124 | Papain-like protease (SARS coronavirus) inhibitor | 0.124 0.073 DBMET01915 | DBMET01915 | |
| 0.036 | 0.634 | 0.333 | NOS3 expression enhancer | 0.333 0.013 DBMET01916 0.284 0.02 DBMET01917 | DBMET01916 | |
| 0.012 | 0.614 | 0.127 | M18 aspartyl aminopeptidase inhibitor | 0.127 0.065 DBMET01915 | DBMET01915 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |